Authors
Loading...
Multi-omics analysis identifies YAP1 as a resistance factor in gastric cancer, enhancing therapy with novel nanoparticles.
Qiu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: